Cefazaflur has a broad-spectrum of in vitro antibacterial activity equal to or greater than that of the commercially-available cephalosporins.
In addition, cefazaflur has activity against isolates of Enterobacter, Citrobacter and indole-positive Proteus; however, this activity decreased markedly when the MIC determinations were carried out with a large inoculum size.
A similar inoculum effect was observed with cefamandole, however, cefoxitin's activity was relatively unchanged at increased inoculum sizes. Human serum had a relatively small effect on the in vitro activity of cefazaflur. The inactivated, pooled batch of serum when added to the medium constituted 50% of the final test medium.
Cefazolin (SK&F), cephalothin (Lilly), cephapirin (Bristol), and cephaloridine (Lilly) were obtained as commercial preparations.
Cefazaflur and cefamandole were prepared in our laboratory and the other experimental cephalosporins were kindly supplied as research samples (cefoxitin , Merck; cefuroxime, Glaxo).
Results and Discussion Table I THE JOURNAL OF ANTIBIOTICS Cefazaflur activity against the most common gram-negative bacteria also was of high order. Cefazaflur was clearly more active than cefazolin, cephalothin and cephaloridine against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis (Figs. 2, 3, 4) . In addition, cefazaflur was active against Enterobacter species whereas cephalothin and cephaloridine were inactive against these bacteria (Fig. 5) A series of studies which are summarized in Table 2 , were then carried out to examine the effect of human serum on the activity of cefazaflur and control cephalosporins. Fig. 6 shows the activity Fig. 7 . Again, the activity of all of the cephalosporins was reduced in serum, however, the median MIC value for cefazaflur in serum (0.8 mcg/ml) was clearly superior to cefazolin (6.3 mcg/ml), cephalothin (25 mcg/ml) and cephapirin (25 mcg/ml). Against P. mirabilis and K. pneumoniae isolates, cefazolin and cephalothin showed a 4-fold loss in median MIC values whereas cefazaflur and cephapirin showed little or no change in activity (Figs. 8, 9 ). Of the four cephalosporins examined for serum effects against E. aerogenes, only cefazaflur and cefazolin showed significant activity (Fig. 10) . Cefazaflur was clearly more active than cefazolin against E. aerogenes in both broth and serum. It is of interest to note that although cephalothin is less bound to serum proteins than is cefazolin (65% vs. 85%), its activity in the presence of serum was poorer than that of cefazolin. Cephalothin has been reported to be degraded in vitro by human serum after incubation at 37°C8).
The effect of inoculum size on in vitro activity of cefazaflur and control cephalosporins was next examined. In these studies, 10 organisms each of S. aureus, E. coli, K. pneumoniae, indole-positive Proteus, Enterobacter species and Citrobacter at various inoculum sizes were tested against seven parenteral cephalosporins. Table 3 shows the results obtained with S. aureus, E. coli and K. pneumoniae isolates. Cefazaflur, cefamandole, cephalothin and cefazolin all experienced a 4-fold increase in the median MIC values against S. aureus when the inoculum size was increased from 105 to 101 organisms/ ml. Cephapirin showed an 8-fold loss in activity but no significant inoculum effect was observed with cefoxitin or cefuroxime. Against E. coli, cefazaflur showed a significant activity loss at the high inoculum size and 6.3 mcg/ml were required to inhibit 50% of the isolates. The median MIC for cephalothin (50 mcg/ml) and cephapirin (100 mcg/ml) at this high inoculum size also had increased significantly. Against Klebsiella isolates, there was less of an inoculum effect; however, the MIC values for cephalothin and cephapirin at an inoculum size of 107 organisms/ml was relatively poor (12.5 mcg/ml).
A more dramatic effect of inoculum size was observed with organisms that tend to show a variable response to the newer cephalosporins (Table 4) . Against these bacterial isolates (Citrobacter, indolepositive Proteus and Enterobacter sp.), cefazaflur showed good median MIC values at inoculum sizes ranging for 104 to 108 organisms/ml. At an inoculum level of 107 organisms/ml, cefazaflur showed poor activity against strains of indole-positive Proteus and similar poor activity at 108 organisms/ml against Enterobacter species. Cefamandole showed a similar inoculum response but tended to be more active than cefazaflur against these organisms. Cefoxitin shows very little change in activity with increased inoculum size but was generally poor against the Enterobacter species. Cefuroxime was intermediate in response between cefoxitin and cephamandole, but, some break in activity was observed at the higher inoculum size especially against isolates of indole-positive Proteus. COUNTS recently reported a similar high inoculum effect with indole-positive Proteus and Enterobacter species5).
